CeriBell, Inc. (NASDAQ:CBLL) Short Interest Update

CeriBell, Inc. (NASDAQ:CBLL) was the target of a large increase in short interest in February. As of February 27th, there was short interest totaling 1,925,021 shares, an increase of 16.0% from the February 12th total of 1,659,458 shares. Based on an average daily trading volume, of 292,834 shares, the short-interest ratio is presently 6.6 days. Approximately 6.4% of the shares of the stock are short sold. Approximately 6.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 292,834 shares, the short-interest ratio is presently 6.6 days.

Wall Street Analyst Weigh In

A number of research firms recently commented on CBLL. BTIG Research restated a “buy” rating and set a $30.00 price target on shares of CeriBell in a research report on Wednesday, January 28th. TD Cowen reissued a “buy” rating on shares of CeriBell in a research note on Tuesday, December 9th. Finally, Canaccord Genuity Group increased their target price on CeriBell from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $24.67.

Insider Buying and Selling at CeriBell

In related news, CTO Raymond Woo sold 11,112 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $21.18, for a total value of $235,352.16. Following the sale, the chief technology officer owned 167,317 shares of the company’s stock, valued at $3,543,774.06. The trade was a 6.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Scott Blumberg sold 36,000 shares of CeriBell stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $21.00, for a total value of $756,000.00. Following the transaction, the chief financial officer directly owned 118,842 shares of the company’s stock, valued at approximately $2,495,682. The trade was a 23.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 239,627 shares of company stock worth $4,912,660 over the last three months. 20.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CeriBell

Several institutional investors and hedge funds have recently modified their holdings of CBLL. Caitong International Asset Management Co. Ltd boosted its position in shares of CeriBell by 3,971.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after buying an additional 1,231 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in CeriBell during the 3rd quarter worth approximately $33,000. CWM LLC grew its stake in shares of CeriBell by 1,178.5% during the 4th quarter. CWM LLC now owns 1,841 shares of the company’s stock worth $40,000 after acquiring an additional 1,697 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of CeriBell by 353.8% in the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after purchasing an additional 1,801 shares during the last quarter. Finally, Ameritas Investment Partners Inc. raised its holdings in shares of CeriBell by 97.5% in the second quarter. Ameritas Investment Partners Inc. now owns 2,544 shares of the company’s stock valued at $48,000 after purchasing an additional 1,256 shares during the last quarter.

CeriBell Trading Up 1.5%

CBLL stock traded up $0.29 during midday trading on Tuesday, reaching $19.45. The company’s stock had a trading volume of 31,690 shares, compared to its average volume of 340,130. The company has a quick ratio of 9.35, a current ratio of 9.73 and a debt-to-equity ratio of 0.13. CeriBell has a 52 week low of $10.01 and a 52 week high of $24.33. The business’s 50-day simple moving average is $20.41 and its 200-day simple moving average is $16.82. The stock has a market cap of $732.25 million, a PE ratio of -13.23 and a beta of 1.13.

CeriBell (NASDAQ:CBLL) last announced its quarterly earnings results on Tuesday, February 24th. The company reported ($0.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.07. The business had revenue of $24.78 million for the quarter, compared to the consensus estimate of $23.95 million. CeriBell had a negative net margin of 59.97% and a negative return on equity of 31.77%. As a group, sell-side analysts expect that CeriBell will post -2.46 EPS for the current year.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.